HRT FINANCIAL LP

Position in GSK — GSK plc

CIK 1475597 NEW YORK, NY

Position in GSK

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$31,656,542

+$8,162,877 QoQ

Shares Held

603,902

+41.9% QoQ

Ownership

0.030%

of shares outstanding

% of Portfolio

0.09%

of 13F equity value

Holder Rank

#55

of 1,033 holders

Holding Since

Mar 2021

12 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

HRT FINANCIAL LP holds $691,078,789 across 12 Drug Manufacturers - General names. GSK ranks #6 (4.6% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	1,031,961	$262,087,135
2	ABBV	AbbVie Inc.	702,907	$176,879,517
3	MRK	Merck & Co., Inc.	798,048	$102,549,168
4	LLY	ELI LILLY & Co	38,616	$46,317,192
5	BMY	Bristol Myers Squibb Co	741,187	$42,707,194
6	GSK	GSK plc This page	603,902	$31,656,542
7	NVS	Novartis AG	89,587	$14,040,074
8	NVO	Novo Nordisk A S	148,940	$7,140,183

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$31,656,542	603,902	+41.9%	Shares	Defined	2026-08-14
2026-03-31	$23,493,665	425,687	+43.9%	Shares	Defined	2026-05-14
2025-12-31	$14,503,432	295,747	+842.8%	Shares	Defined	2026-02-12
2025-06-30	$1,204,608	31,370	-71.7%	Shares	Defined	2025-08-14
2024-09-30	$4,527,010	110,739	-38.5%	Shares	Defined	2024-11-12
2024-03-31	$7,717,500	180,021	-65.2%	Shares	Defined	2024-05-13
2023-12-31	$19,144,603	516,584	+2689.6%	Shares	Defined	2024-02-09
2023-09-30	$671,277	18,518	-78.4%	Shares	Defined	2023-11-13
2022-09-30	$2,524,887	85,793	+481.1%	Shares	Defined	2022-11-14
2022-06-30	$630,294	14,763	+0.1%	Shares	Defined	2022-08-12
2022-03-31	$629,874	14,743	-79.7%	Shares	Defined	2022-05-16
2021-03-31	$2,545,580	72,721	—	Shares	Defined	2021-05-17
No filing history on record for this holder in this stock.